Epidemiology of Lung Cancer
Lung cancer continues to be one of the most common causes of cancer death despite understanding the major cause of the disease: cigarette smoking.
Lung cancer continues to be one of the most common causes of cancer death despite understanding the major cause of the disease: cigarette smoking.
Cannabis sativa has long been used for medicinal purposes.
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians.
The Cannabis plant has been used for many of years as a medicinal agent in the relief of pain and seizures.
Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms (including nausea, anorexia, and neuropathic pain) in the palliative treatment of cancer patients.
A subset of patients with multiple sclerosis (MS) smoke cannabis to relieve symptoms including spasticity and pain.
This study was to provide the most up-to-date scientific evidence of the potential analgesic effects, or lack thereof, of the marijuana plant
Many cultures throughout history have used cannabis to treat a variety of painful ailments. Neuropathic pain is a complicated condition that is challenging to treat with our current medications.
Purpose of review: An increasing number of patients are turning to cannabis and cannabinoids for management of their palliative and nonpalliative cancer pain and other cancer-related symptoms. Canadians have a legal framework for access to medical cannabis, which provides a unique perspective in a setting lacking robust clinical evidence. This review seeks to delineate the role of cannabis and cannabinoids in cancer pain management and offers insight into the Canadian practice.
Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems.